成人急性肝功能衰竭:病因、临床表现和诊断
- Authors
- Eric Goldberg, MD
Eric Goldberg, MD
- Associate Professor of Medicine
- University of Maryland School of Medicine
- Sanjiv Chopra, MD, MACP
Sanjiv Chopra, MD, MACP
- Editor-in-Chief — Gastroenterology/Hepatology
- Section Editor — General Hepatology; Gallbladder and Biliary Tract Disease
- Professor of Medicine
- Harvard Medical School
- Senior Consultant in Hepatology
- James Tullis Firm Chief
- Beth Israel Deaconess Medical Center
- Section Editor
- Robert S Brown, Jr, MD, MPH
Robert S Brown, Jr, MD, MPH
- Section Editor — Liver Transplantation
- Vice Chair, Transitions of Care, Department of Medicine
- Interim Chief, Division of Gastroenterology and Hepatology
- Weill Cornell Medical College
- Professor of Clinical Medicine, Columbia University College of Physicians & Surgeons
- Deputy Editor
- Anne C Travis, MD, MSc, FACG, AGAF
Anne C Travis, MD, MSc, FACG, AGAF
- Deputy Editor — Gastroenterology/Hepatology
- Assistant Professor of Medicine, Part-time
- Harvard Medical School
引言
急性肝功能衰竭以急性肝损伤、肝性脑病及凝血酶原时间/国际标准化比值(international normalized ratio, INR)延长为主要特征。也称为暴发性肝功能衰竭、急性肝坏死、暴发性肝坏死及暴发性肝炎。若不治疗,预后极差,因此对急性肝功能衰竭患者及时诊断和治疗至关重要[1]。只要可能,急性肝功能衰竭患者应收治在具有肝移植能力的医疗机构的重症监护病房。
本专题将总结成人急性肝功能衰竭的病因、临床表现和诊断。急性肝功能衰竭患者的预后和治疗将单独讨论。 (参见“成人急性肝衰竭:处理与预后”)
下文的讨论与2011美国肝脏病研究协会(American Association for the Study of Liver Diseases, AASLD)急性肝功能衰竭治疗指南(guideline)一致[2]。
定义
急性肝功能衰竭指无肝硬化或既往无肝病的患者发生严重的急性肝损伤伴脑病和肝脏合成功能受损(INR≥1.5)[2,3]。虽然不同报告对区分急、慢性肝功能衰竭的病程不同,但常用以病程小于26周作为临界值。
病前未诊断的Wilson病、垂直传播乙型肝炎病毒感染或自身免疫性肝炎患者有可能已经存在肝硬化,如果病程小于26周,也诊断为急性肝功能衰竭。另一方面,急性重度酒精性肝炎患者即使病程不足26周,仍认为是慢加急性肝衰竭,因为大部分患者有长期酗酒史。此类患者将在别处讨论。 (参见“酒精性脂肪性肝病和酒精性肝硬化的临床表现和诊断”和“酒精性脂肪肝和酒精性肝硬化的预后和管理”)
Subscribers log in here
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:Literature review current through: 2017-06 . | This topic last updated: 2015-08-12.The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.References- Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: Summary of a workshop. Hepatology 2008; 47:1401.
- http://www.aasld.org/practiceguidelines/Documents/AcuteLiverFailureUpdate2011.pdf (Accessed on August 08, 2012).
- Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55:965.
- Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993; 22:257.
- Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol 2001; 33:191.
- Wright G, Wilmore S, Makanyanga J, et al. Liver transplant for adult hemophagocytic lymphohistiocytosis: case report and literature review. Exp Clin Transplant 2012; 10:508.
- Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008; 28:142.
- O'Grady JG, Portmann B, Williams R. Fulminant hepatic failure. In: Diseases of the Liver, Schiff L, Schiff R (Eds), Lippincott, Philadelphia 1993.
- Oketani M, Ido A, Tsubouchi H. Changing etiologies and outcomes of acute liver failure: A perspective from Japan. J Gastroenterol Hepatol 2011; 26 Suppl 1:65.
- Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am 2000; 14:605.
- Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21:240.
- Wright TL, Mamish D, Combs C, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339:952.
- Chu CM, Yeh CT, Liaw YF. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45:613.
- Lee WM. Acute liver failure. N Engl J Med 1993; 329:1862.
- Muñoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liver Dis 1993; 13:395.
- Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000; 32:536.
- Kaufman B, Gandhi SA, Louie E, et al. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis 1997; 24:334.
- Schiødt FV, Balko J, Schilsky M, et al. Thrombopoietin in acute liver failure. Hepatology 2003; 37:558.
- Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012; 56:129.
- Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol 2012; 57:780.
- Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995; 345:163.
- O'Grady JG, Williams R. Acute liver failure. In: Gastrointestinal emergencies, Gilmore IT, Shields R (Eds), WB Saunders, Eastbourne 1992. p.104.
- Mas A, Rodés J. Fulminant hepatic failure. Lancet 1997; 349:1081.
- Shakil AO, Jones BC, Lee RG, et al. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000; 45:334.
- Poff JA, Coakley FV, Qayyum A, et al. Frequency and histopathologic basis of hepatic surface nodularity in patients with fulminant hepatic failure. Radiology 2008; 249:518.
- Chavarria L, Alonso J, Rovira A, Córdoba J. Neuroimaging in acute liver failure. Neurochem Int 2011; 59:1175.
- Amini M, Runyon BA. Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy. World J Gastroenterol 2010; 16:4905.
- Mochida S, Takikawa Y, Nakayama N, et al. Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res 2011; 41:805.
Top